COVID-19 Expert opinions
Expert opinions for hematologists in COVID-19 crisis
COVID-19, caused by SARS-CoV-2, is expected to be a devastating infection in many patients with hematologic diseases. It should be taken seriously and managed rigorously without jeopardizing the curative chance of individual patients.
Please note that the following sections express expert opinions but should not be regarded as formal guidelines.
FAQ by EHA Scientific Working Group Infections in Hematology
In view of the rapidly changing evidence and general situation, the EHA Scientific Working Group Infections in Hematology has developed key questions and answers on the management of cancer patients with or at risk of COVID-19.
Expert opinions for specific hematologic malignancies
EHA SWGs are providing their expert opinions regarding COVID-19 and specific hematologic malignancies.
Expert opinions for specific non-malignant hematologic diseases
Collection of expert opinions regarding COVID-19 and specific non-malignant hematologic diseases.
COVID-19 - Impact on childhood hematology patients
The EHA SWG on pediatrics has analyzed the impact and the risk of COVID-19 on pediatric hematology patients.
Managing hematological cancer patients during the COVID-19 pandemic
An ESMO-EHA Interdisciplinary Expert Consensus.
Back